Circulating MiR-210 As a Novel Hypoxia Marker in Pancreatic Cancer
Overview
Authors
Affiliations
MicroRNA are small noncoding transcripts involved in many cellular mechanisms, including tumorigenesis. miR-210, in particular, is induced by hypoxia and correlates with adverse outcomes in certain cancers. Because pancreatic adenocarcinomas exhibit extremely hypoxic signatures, we hypothesized that miR-210 may serve as a diagnostic marker for screening or surveillance for pancreatic cancer. Plasma samples were obtained from newly diagnosed pancreatic cancer patients and age-matched noncancer controls. miRNA was extracted directly from plasma and reverse-transcribed to complementary DNA. A known quantity of synthetic Caenorhabditis elegans miR-54 (celmiR-54) was added for normalization. miR-210 and cel-miR-54 were then measured using quantitative reverse transcription polymerase chain reaction. An initial cohort of 11 pancreatic cancer patients and 14 age-matched controls was used as the test set and a second cohort of 11 pancreatic cancer patients and 11 controls was used as the validating set in this study. miR-210 was reliably detected and quantified, with a statistically significant four-fold increase in expression in pancreatic cancer patients compared with normal controls (P < .00004) in the test set. This difference was confirmed in the validation group (P < .018). In summary, circulating miR-210 levels are elevated in pancreatic cancer patients and may potentially serve as a useful biomarker for pancreatic cancer diagnosis.
MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential.
Dong F, Zhou J, Wu Y, Gao Z, Li W, Song Z Front Cell Dev Biol. 2025; 12:1499111.
PMID: 39882259 PMC: 11774998. DOI: 10.3389/fcell.2024.1499111.
The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer.
Vitale F, Zileri Dal Verme L, Paratore M, Negri M, Nista E, Ainora M Biomedicines. 2025; 12(12.
PMID: 39767746 PMC: 11673965. DOI: 10.3390/biomedicines12122840.
Using microRNAs Networks to Understand Pancreatic Cancer-A Literature Review.
Przybyszewski O, Mik M, Nowicki M, Kusinski M, Mikolajczyk-Solinska M, Sliwinska A Biomedicines. 2024; 12(8).
PMID: 39200178 PMC: 11351910. DOI: 10.3390/biomedicines12081713.
Imamura T, Komatsu S, Nishibeppu K, Kiuchi J, Ohashi T, Konishi H BMC Cancer. 2024; 24(1):907.
PMID: 39069624 PMC: 11283702. DOI: 10.1186/s12885-024-12676-x.
Role of MicroRNA in Hypoxic Tumours and their Potential as Biomarkers for Early Detection of Cancer.
Jayashree P, Kalpita M, Judith T, Singh A, Ashwin K Curr Mol Med. 2024; 24(5):525-536.
PMID: 38310548 DOI: 10.2174/0115665240268661231128094831.